Regulatory T and B cells in peripheral blood of subcutaneous immunotherapy-treated Japanese cedar pollinosis patients

Papers of special note have been highlighted as: • of interest

References

• 1 Jacobsen L, Niggemann B, Dreborg S et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 62, 943–948 (2007).
  Medline CASGoogle Scholar
• 2 Durham SR, Walker SM, Varga EM et al. Long-term clinical efficacy of grass-pollen immunotherapy. N. Engl. J. Med. 341, 468–475 (1999).
  Medline CASGoogle Scholar
• 3 Bonifazi F, Jutel M, Bilo BM, Birnbaum J, Muller U. Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice. Allergy 60, 1459–1470 (2005).
  Medline CASGoogle Scholar
• 4 Bohle B. Immune mechanisms of SCIT and SLIT: facing possible differences? Clin. Exp. Allergy 44, 304–306 (2014).
  Medline CASGoogle Scholar
• 5 Okamoto Y, Horiguchi S, Yamamoto H, Yonekura S, Hanazawa T. Present situation of cedar pollinosis in Japan and its immune responses. Allergol. Int. 58, 155–162 (2009).
  Medline CASGoogle Scholar
• 6 Yamada T, Saito H, Fujieda S. Present state of Japanese cedar pollinosis: the national affliction. J. Allergy Clin. Immunol. 133, 632–639 (2014).
  MedlineGoogle Scholar
• 7 Okubo K, Gotoh M. Allergen immunotherapy for allergic rhinitis. J. Nippon Med. Sch. 77, 285–289 (2010).
  MedlineGoogle Scholar
• 8 Wachholz PA, Durham SR. Induction of ‘blocking’ IgG antibodies during immunotherapy. Clin. Exp. Allergy 33, 1171–1174 (2003).
  Medline CASGoogle Scholar
• 9 Bellinghausen I, Metz G, Enk AH, Christmann S, Knop J, Saloga J. Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects. Eur. J. Immunol. 27, 1131–1139 (1997).
  Medline CASGoogle Scholar
• 10 Jutel M, Akdis M, Blaser K, Akdis CA. Mechanisms of allergen specific immunotherapy – T-cell tolerance and more. Allergy 61, 796–807 (2006).
  Medline CASGoogle Scholar
• 11 van de Veen W, Stanic B, Yaman G et al. IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses. J. Allergy Clin. Immunol. 131, 1204–1212 (2013). • Shows that human IL-10-producing B cells produced a large amount of IgG4, and were designated as B regulatory 1 (Br1) cells.
  Medline CASGoogle Scholar
• 12 Ozdemir C, Akdis M, Akdis CA. T regulatory cells and their counterparts: masters of immune regulation. Clin. Exp. Allergy 39, 626–639 (2009).
  Medline CASGoogle Scholar
• 13 Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151–1164 (1995).
  Medline CASGoogle Scholar
• 14 Miyara M, Yoshioka Y, Kitoh A et al. Functional delineation and differentiation dynamics of human CD4⁺ T cells expressing the FoxP3 transcription factor. Immunity 30, 899–911 (2009).
  Medline CASGoogle Scholar
• 15 Sugiyama D, Nishikawa H, Maeda Y et al. Anti-CCR4 mAb selectively depletes effector-type Foxp3⁺ CD4⁺ regulatory T cells, evoking antitumor immune responses in humans. Proc. Natl Acad. Sci. USA 110, 17945–17950 (2013).
  Medline CASGoogle Scholar
• 16 Chen W, Jin W, Hardegen N et al. Conversion of peripheral CD4⁺ CD25⁻ naive T cells to CD4⁺ CD25⁺ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198, 1875–1886 (2003).
  Medline CASGoogle Scholar
• 17 Roncarolo MG, Gregori S, Battaglia M, Bacchetta R, Fleischhauer K, Levings MK. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev. 212, 28–50 (2006).
  Medline CASGoogle Scholar
• 18 Gagliani N, Magnani CF, Huber S et al. Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nat. Med. 19, 739–746 (2013). • This article is the first to report that the coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells.
  Medline CASGoogle Scholar
• 19 Lou W, Wang C, Wang Y, Han D, Zhang L. Responses of CD4⁺ CD25⁺ Foxp3⁺ and IL-10-secreting type I T regulatory cells to cluster-specific immunotherapy for allergic rhinitis in children. Pediatr. Allergy Immunol. 23, 140–149 (2012).
  MedlineGoogle Scholar
• 20 Aalberse RC, Stapel SO, Schuurman J, Rispens T. Immunoglobulin G4: an odd antibody. Clin. Exp. Allergy 39, 469–477 (2009).
  Medline CASGoogle Scholar
• 21 van de Veen W, Stanic B, Wirz OF, Jansen K, Globinska A, Akdis M. Role of regulatory B cells in immune tolerance to allergens and beyond. J. Allergy Clin. Immunol. 138, 654–665 (2016).
  Medline CASGoogle Scholar
• 22 Saraiva M, O’Garra A. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 10, 170–181 (2010).
  Medline CASGoogle Scholar
• 23 Deluce-Kakwata-nkor N, Lamendour L, Chabot V et al. Differentiation of human dendritic cell subsets for immune tolerance induction. Transfus. Clin. Biol. 25, 90–95 (2018).
  Medline CASGoogle Scholar
• 24 Yamanaka K, Yuta A, Kakeda M et al. SLIT improves cedar pollinosis by restoring IL-10 production from Tr1 and monocytes approximately IL-10 productivity is critical for becoming allergic approximately. Allergol. Int. 60, 45–51 (2011).
  Medline CASGoogle Scholar
• 25 White AM, Wraith DC. Tr1-like T cells: an enigmatic regulatory t cell lineage. Front. Immunol. 7, 1–7 (2016).
  MedlineGoogle Scholar
• 26 Hossain DMS, Panda AK, Manna A et al. Foxp3 acts as a cotranscription factor with STAT3 in tumor-induced regulatory T cells. Immunity 39, 1057–1069 (2013).
  Medline CASGoogle Scholar
• 27 Apetoh L, Quintana FJ, Pot C et al. The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat. Immunol. 11, 854–861 (2010).
  Medline CASGoogle Scholar
• 28 Iwasaki Y, Fujio K, Okamura T et al. Egr-2 transcription factor is required for Blimp-1-mediated IL-10 production in IL-27-stimulated CD4⁺ T cells. Eur. J. Immunol. 43, 1063–1073 (2013).
  Medline CASGoogle Scholar
• 29 Motomura Y, Kitamura H, Hijikata A et al. The transcription factor E4BP4 regulates the production of IL-10 and IL-13 in CD4⁺ T cells. Nat. Immunol. 12, 450–459 (2011). • Shows that E4BP4 has the function in controlling production of IL-10 in CD4+ T cells.
  Medline CASGoogle Scholar
• 30 PG-MARJ-Committee. Practical Guideline for the Management of Allergic Rhinitis in Japan (PG-MARJ) Life Science Tokyo, Japan 27 (2016). • Guidelines provide the basis for the management of allergic rhinitis in Japan.
  Google Scholar
• 31 Gonzalez M, Doña I, Palomares F et al. Dermatophagoides pteronyssinus immunotherapy changes the T-regulatory cell activity. Sci. Rep. 7, 1–11 (2017).
  MedlineGoogle Scholar
• 32 Gómez E, Fernández TD, Doña I et al. Initial immunological changes as predictors for house dust mite immunotherapy response. Clin. Exp. Allergy 45, 1542–1553 (2015).
  Medline CASGoogle Scholar
• 33 Kirmaz C, Ozenturk Kirgiz O, Bayrak P et al. Effects of allergen-specific immunotherapy on functions of helper and regulatory T cells in patients with seasonal allergic rhinitis. Eur. Cytokine Netw. 22, 15–23 (2011).
  Medline CASGoogle Scholar
• 34 Ajduk J, Marinic I, Aberle N, Rabatic S, Gagro A. Effect of house dust mite immunotherapy on transforming growth factor beta1-producing T cells in asthmatic children. Ann. Allergy Asthma Immunol. 100, 314–322 (2008).
  MedlineGoogle Scholar
• 35 Akdis M, Verhagen J, Taylor A et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J. Exp. Med. 199, 1567–1575 (2004).
  Medline CASGoogle Scholar
• 36 Matsuda M, Morie Y, Oze H et al. Phenotype analyses of IL-10-producing Foxp3⁻ CD4⁺ T cells increased by subcutaneous immunotherapy in allergic airway inflammation. Int. Immunopharmacol. 61, 297–305 (2018).
  Medline CASGoogle Scholar
• 37 Matsuda M, Doi K, Tsutsumi T et al. Regulation of allergic airway inflammation by adoptive transfer of CD4⁺ T cells preferentially producing IL-10. Eur. J. Pharmacol. 812, 38–47 (2017).
  Medline CASGoogle Scholar
• 38 Shamji MH, Kappen JH, Akdis M et al. Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper. Allergy 72, 1156–1173 (2017). • Recent review provides a comprehensive overview of recently developed novel biomarkers for monitoring clinical efficacy of allergen immunotherapy.
  Medline CASGoogle Scholar